Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Guidant gets FDA approval for Lifestream:

This article was originally published in Clinica

Executive Summary

US cardiology company Guidant has received US FDA approval to market its ACS over-the-wire Lifestream coronary dilatation catheter. Advanced Cardiovascular Systems, part of Guidant's vascular intervention group, manufactures the device and distribution of the product will begin at once. Guidant says the ACS OTW Lifestream has a 26% reduced crossing profile compared with the ACS Stack 40S catheter and allows physicians to reach and cross more difficult lesions.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts